Roxane Laboratories is seeking FDA approval to make and sell a generic version of Novartis' Famvir herpes medication before the original patent expires, Novartis and two affiliates claim in New Jersey Federal Court.
Categories / Uncategorized
Subscribe to our free newsletters
Our weekly newsletter Closing Arguments offers the latest about ongoing trials, major litigation and rulings in courthouses around the U.S. and the world, while the monthly Under the Lights dishes the legal dirt from Hollywood, sports, Big Tech and the arts.
Additional Reads
-
-
Texans head to the polls for high-stakes US Senate primary February 17, 2026